Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay
Phase of Trial: Phase IV
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 01 Nov 2016 Planned End Date changed from 1 Aug 2018 to 1 Dec 2019.
- 01 Nov 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Nov 2017.